The clinical hold’s removal has been positively received by the market as it signals a step forward for TuHURA’s IFx-2.0, which is being developed as an adjunctive therapy in combination with ...

Approximately 5.1% of Elevation Oncology’s common stock is held by officers, directors, and affiliates who have agreed to tender their shares in support of the merger. The transaction is slated for ...

Mizuho analysts have downgraded Chewy (NYSE: CHWY) to Neutral, removing its "Top Pick" status, stating that the "current ...

Inc to Neutral from Buy given a weaker-than-expected market share gains, rising competition in advanced driver assistance ...

Jefferies analysts maintained a Buy rating on Oracle (NYSE:ORCL) in a note Monday, raising their price target for the stock to $200 from $190 a share.  The firm told investors that it is seeing "more ...

Interactive Brokers was downgraded by Citi to "Neutral" on valuation concerns, whereas Redburn Atlantic raised its price target and reiterated a bullish stance. Citi said the stock’s recent 28% ...

KULR Technology Group Inc (NYSE American:KULR) shares climbed 2% following the announcement that the company has joined the "Bitcoin for Corporations" initiative, signaling a strategic move to ...

Shares of Citius Oncology Inc (NASDAQ: CTOR) soared by 33% following the announcement of a distribution services agreement with Cardinal Health (NYSE: CAH), a maj ...

The double-blind, placebo-controlled study revealed that daily supplementation with Niagen significantly raised blood NAD+ levels by about 140% and improved multiple clinical markers of cardiovascular ...

Morgan Stanley analysts raised their price target for AppLovin (NASDAQ:APP) to $460 from $420 a share in a note Monday, ...

Morgan Stanley downgraded Lululemon Athletica (NASDAQ: LULU) to Equal-weight from Overweight and cut its price target to $280 on waning confidence in a recovery i ...

In a recent report, NATO estimated Canadian defense spending at 1.45% of GDP for 2024, still well below the alliance’s ...